The success of bariatric surgery as treatment of type 2 diabetes should be a call to revitalize anti-obesity drug discovery and development.
Opgenorth
Terry J
TJ
D019440:Anti-Obesity Agents / Q000737:chemistry / Q000627:therapeutic use*; D050110:Bariatric Surgery; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology / Q000601:surgery; D015195:Drug Design; D006801:Humans; D009765:Obesity / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology / Q000601:surgery*; D016896:Treatment Outcome; D015431:Weight Loss
D019440:Anti-Obesity Agents